What is MDxI?
Originally founded in 1993 as Service Strategies, MDxI began as a market research firm specializing in customer satisfaction for Dallas-based companies. Under the leadership of Kathi McGregor, the company expanded its reach nationally, serving Fortune 500 clients in Public Utilities, Financial Services, and Telecommunications. Following an acquisition by Call Solutions, Inc. (later NOVO 1) in 2002, the company pivoted its focus in late 2005 towards medical and scientific product research, with a particular emphasis on In Vitro Diagnostics, leveraging its robust fielding and analytical capabilities. This strategic shift marked a new chapter for the organization, moving beyond its initial market research roots into a more specialized scientific domain.
How much funding has MDxI raised?
MDxI has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for MDxI?
The recent large-scale, late-stage funding indicates MDxI is poised for significant growth and strategic initiatives. This capital infusion is likely to fuel further research and development, market penetration, and potentially the scaling of operations to meet the demands of the In Vitro Diagnostics sector. The company's history of strategic adaptation suggests a forward-thinking approach to market dynamics, positioning it to capitalize on emerging opportunities in the medical technology landscape.
See full MDxI company page
